⌘K

Login Start Free

Home/Filings/4/0000864268-04-000095

4//SEC Filing

GLASSMAN IRIS 4

Accession 0000864268-04-000095

CIK 0000864268other

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 2:53 PM ET

Size

16.5 KB

Accession

0000864268-04-000095

Insider Transaction Report

Form 4

Period: 2004-12-29

BRADLEY PHARMACEUTICALS INCBDY

DirectorTreasurer

Transactions

Discretionary Transaction
Common Stock
2004-12-29$1.31/sh+50,000$65,625→ 139,692 total
Discretionary Transaction
Stock Options (Right to buy)
2004-12-29$1.31/sh−50,000$65,625→ 0 total
Exercise: $1.31From: 2004-12-29Exp: 2004-12-29→ Common Stock (50,000 underlying)

Holdings

Stock Options (Right to buy)
Exercise: $1.06From: 1995-12-05Exp: 2005-12-04→ Common Stock (22,878 underlying)
22,878
Common Stock
(indirect: By Trust)
6,400
Class B Common Stock
16,403
Common Stock
(indirect: By IRA)
4,000
Stock Options (Right to buy)
Exercise: $7.76From: 2002-07-09Exp: 2006-07-08→ Common Stock (30,000 underlying)
30,000
Stock Options (Right to buy)
Exercise: $1.31From: 1996-09-12Exp: 2005-09-11→ Common Stock (18,000 underlying)
18,000
Common Stock
(indirect: By Trust)
5,500
Common Stock
(indirect: By Trust)
15,200
Stock Options (Right to buy)
Exercise: $25.75From: 2005-06-15Exp: 2014-06-14→ Common Stock (5,000 underlying)
5,000

Documents

1 file

4
doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

Entity typeother

Related Parties

1

filerCIK 0001141768

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 2:53 PM ET
Size: 16.5 KB

View on SEC.gov